Physician

Neil Craine Estabrook, M.D.

According to 2025 Medicare claims, Neil Estabrook, M.D. (NPI: 1124317102) practices radiation oncology in the Lafayette-West Lafayette, IN market, with the plurality of this provider's patient population coming from Tippecanoe, IN. This provider's primary affiliated billing organization is ARNETT CLINIC, LLC (NPI: 1164490843; TIN: 352030653) and primary practice location at 47904-2848. Estabrook is affiliated with the IRCCO (ACO ID: A2619) and Indiana University Health ACO, Inc. (ACO ID: D0034), participating under both the MSSP and REACH models.

Estabrook's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 318 traditional Medicare patients, billed 4,904 HCPCS/CPT codes, and received $653,318 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 394 prescription claims across 160 beneficiaries totaling $29,714 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 1 records totaling $30. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $599 to $29,714. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	62	1,005	$159,455
2017	144	2,716	$432,094
2018	227	4,543	$698,639
2019	236	5,570	$842,163
2020	269	5,348	$817,762
2021	291	5,203	$823,987
2022	290	4,906	$708,327
2023	310	5,268	$782,225
2024	318	4,904	$653,318

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	14	35	$599
2017	37	64	$1,641
2018	73	165	$6,263
2019	92	246	$7,156
2020	102	375	$38,455
2021	118	374	$18,361
2022	123	306	$28,203
2023	158	398	$21,370
2024	160	394	$29,714

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	79	79	$160
77334	Design and construction of complex radiation treatment device	77	392	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	119	182	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	130	167	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	183	260	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	150	8,015	$1,648
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	148	$504
Mometasone Furoate	Mometasone Furoate	15	361	$303
Bicalutamide	Bicalutamide	26	364	$285
Silver Sulfadiazine	Silver Sulfadiazine	21	485	$133

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$30	PROGENICS PHARMACEUTICALS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Neil Craine Estabrook, M.D.?

Tedicare shows public-source Medicare data for Neil Craine Estabrook, M.D. (NPI 1124317102), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Neil Craine Estabrook, M.D. have ACO affiliation data?

Neil Craine Estabrook, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and Indiana University Health ACO, Inc. (REACH, ACO ID D0034).

What billing organization is linked to Neil Craine Estabrook, M.D.?

Neil Craine Estabrook, M.D. is linked to ARNETT CLINIC, LLC (billing NPI 1164490843) in the available physician profile data.

Does Neil Craine Estabrook, M.D. have Open Payments data?

Neil Craine Estabrook, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.